Trial Profile
A single center, open label, randomized, 2-period, cross-over, Phase I study to investigate the pharmacokinetic interaction between ACT-064992 and ketoconazole in healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Aug 2014
Price :
$35
*
At a glance
- Drugs Macitentan (Primary) ; Ketoconazole
- Indications Eisenmenger complex; Glioblastoma; Idiopathic pulmonary fibrosis; Mycoses; Pulmonary arterial hypertension; Skin ulcer
- Focus Pharmacokinetics
- 14 Aug 2014 New trial record